LRRK2 and Ehlers-Danlos syndrome: There was no risk of EDS in patients with LRRK2 variants (Additional file 1: Fig. S2a, S2b), or in the subgroup of patients with the LRRK2 G2019S variant (Additional file 1: Fig. S2c).